Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125904722 | 12590472 | 2 | F | 201401 | 20160727 | 20160725 | 20160805 | EXP | DK-BAXTER-2016BAX038153 | BAXTER | ANDERSEN N, BOYSEN A, ROSSEN P, LUCKE A, SAFWAT A. BILATERAL AVASCULAR NECROSIS OF THE FEMORAL HEAD FOLLOWING TREATMENT OF EWING^S SARCOMA. ACTA ONCOLOGICA. 2016 JAN 01;55 (6):792-795. | 28.00 | YR | M | Y | 0.00000 | 20160805 | MD | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125904722 | 12590472 | 1 | PS | HOLOXAN | IFOSFAMIDE | 1 | Unknown | DAYS 1-3 | 19763 | 3 | MG/M**2 | POWDER FOR SOLUTION FOR INJECTION | |||||||
| 125904722 | 12590472 | 2 | SS | HOLOXAN | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | PUMP OVER 14 DAYS | 19763 | ||||||||||
| 125904722 | 12590472 | 3 | SS | HOLOXAN | IFOSFAMIDE | 1 | Unknown | DAYS 1-2 | 19763 | 3 | MG/M**2 | ||||||||
| 125904722 | 12590472 | 4 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | DAY 1 | 0 | 1.5 | MG/M**2 | ||||||||
| 125904722 | 12590472 | 5 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | DAY 1 | 0 | 1.5 | MG/M**2 | ||||||||
| 125904722 | 12590472 | 6 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | DAYS 1-3 | 0 | 20 | MG/M**2 | ||||||||
| 125904722 | 12590472 | 7 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | DAYS 1-3 | 0 | 150 | MG/M**2 | ||||||||
| 125904722 | 12590472 | 8 | SS | ACTINOMYCIN D | DACTINOMYCIN | 1 | Unknown | DAYS 1-2 | 0 | .75 | MG/M**2 | ||||||||
| 125904722 | 12590472 | 9 | C | IRINOTECAN | IRINOTECAN | 1 | Unknown | DAYS 1-5 | 0 | 10 | MG/M**2 | ||||||||
| 125904722 | 12590472 | 10 | C | IRINOTECAN | IRINOTECAN | 1 | 0 | ||||||||||||
| 125904722 | 12590472 | 11 | C | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Unknown | DAYS 1-5 | 0 | 100 | MG/M**2 | ||||||||
| 125904722 | 12590472 | 12 | C | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | 0 | ||||||||||||
| 125904722 | 12590472 | 13 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | DAYS 1-5 | 0 | 250 | MG/M**2 | ||||||||
| 125904722 | 12590472 | 14 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | 0 | ||||||||||||
| 125904722 | 12590472 | 15 | C | TOPOTECAN | TOPOTECANTOPOTECAN HYDROCHLORIDE | 1 | Unknown | DAYS 1-5 | 0 | .75 | MG/M**2 | ||||||||
| 125904722 | 12590472 | 16 | C | TOPOTECAN | TOPOTECANTOPOTECAN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125904722 | 12590472 | 17 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125904722 | 12590472 | 1 | Ewing's sarcoma |
| 125904722 | 12590472 | 4 | Ewing's sarcoma |
| 125904722 | 12590472 | 6 | Ewing's sarcoma |
| 125904722 | 12590472 | 7 | Ewing's sarcoma |
| 125904722 | 12590472 | 8 | Ewing's sarcoma |
| 125904722 | 12590472 | 9 | Ewing's sarcoma |
| 125904722 | 12590472 | 10 | Metastases to lung |
| 125904722 | 12590472 | 11 | Ewing's sarcoma |
| 125904722 | 12590472 | 12 | Metastases to lung |
| 125904722 | 12590472 | 13 | Ewing's sarcoma |
| 125904722 | 12590472 | 14 | Disease progression |
| 125904722 | 12590472 | 15 | Ewing's sarcoma |
| 125904722 | 12590472 | 16 | Disease progression |
| 125904722 | 12590472 | 17 | Antiemetic supportive care |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125904722 | 12590472 | OT |
| 125904722 | 12590472 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125904722 | 12590472 | Osteonecrosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125904722 | 12590472 | 1 | 201309 | 0 | ||
| 125904722 | 12590472 | 4 | 201309 | 0 | ||
| 125904722 | 12590472 | 6 | 201309 | 0 | ||
| 125904722 | 12590472 | 7 | 201309 | 0 | ||
| 125904722 | 12590472 | 8 | 201309 | 0 |